139 related articles for article (PubMed ID: 16989776)
1. Parafibromin inhibits cancer cell growth and causes G1 phase arrest.
Zhang C; Kong D; Tan MH; Pappas DL; Wang PF; Chen J; Farber L; Zhang N; Koo HM; Weinreich M; Williams BO; Teh BT
Biochem Biophys Res Commun; 2006 Nov; 350(1):17-24. PubMed ID: 16989776
[TBL] [Abstract][Full Text] [Related]
2. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
3. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
4. HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome.
Wang PF; Tan MH; Zhang C; Morreau H; Teh BT
Horm Metab Res; 2005 Jun; 37(6):380-3. PubMed ID: 16001331
[TBL] [Abstract][Full Text] [Related]
5. Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin.
Hahn MA; Marsh DJ
Oncogene; 2005 Sep; 24(41):6241-8. PubMed ID: 16116486
[TBL] [Abstract][Full Text] [Related]
6. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
7. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical assessment of parafibromin in mouse and human tissues.
Porzionato A; Macchi V; Barzon L; Masi G; Iacobone M; Parenti A; Palù G; De Caro R
J Anat; 2006 Dec; 209(6):817-27. PubMed ID: 17118068
[TBL] [Abstract][Full Text] [Related]
9. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma.
Tan MH; Morrison C; Wang P; Yang X; Haven CJ; Zhang C; Zhao P; Tretiakova MS; Korpi-Hyovalti E; Burgess JR; Soo KC; Cheah WK; Cao B; Resau J; Morreau H; Teh BT
Clin Cancer Res; 2004 Oct; 10(19):6629-37. PubMed ID: 15475453
[TBL] [Abstract][Full Text] [Related]
10. Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen.
Iwata T; Mizusawa N; Taketani Y; Itakura M; Yoshimoto K
Oncogene; 2007 Sep; 26(42):6176-83. PubMed ID: 17404568
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA.
Farber LJ; Kort EJ; Wang P; Chen J; Teh BT
Mol Carcinog; 2010 Mar; 49(3):215-23. PubMed ID: 19908240
[TBL] [Abstract][Full Text] [Related]
12. Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function.
Lin L; Czapiga M; Nini L; Zhang JH; Simonds WF
Mol Cancer Res; 2007 Feb; 5(2):183-93. PubMed ID: 17314275
[TBL] [Abstract][Full Text] [Related]
13. Analysis of aberrantly spliced HRPT2 transcripts and the resulting proteins in HPT-JT syndrome.
Moon S; Kim JH; Shim JY; Ahn YB; Song KH; Cha BY; Maeng LS; Han JH
Mol Genet Metab; 2010 Aug; 100(4):365-71. PubMed ID: 20541447
[TBL] [Abstract][Full Text] [Related]
14. Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene.
Zhao J; Yart A; Frigerio S; Perren A; Schraml P; Weisstanner C; Stallmach T; Krek W; Moch H
Oncogene; 2007 May; 26(23):3440-9. PubMed ID: 17130827
[TBL] [Abstract][Full Text] [Related]
15. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.
Yart A; Gstaiger M; Wirbelauer C; Pecnik M; Anastasiou D; Hess D; Krek W
Mol Cell Biol; 2005 Jun; 25(12):5052-60. PubMed ID: 15923622
[TBL] [Abstract][Full Text] [Related]
16. Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome.
Panicker LM; Zhang JH; Dagur PK; Gastinger MJ; Simonds WF
Endocr Relat Cancer; 2010 Jun; 17(2):513-24. PubMed ID: 20304979
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
18. Nucleolar localization of parafibromin is mediated by three nucleolar localization signals.
Hahn MA; Marsh DJ
FEBS Lett; 2007 Oct; 581(26):5070-4. PubMed ID: 17923126
[TBL] [Abstract][Full Text] [Related]
19. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.
Masi G; Barzon L; Iacobone M; Viel G; Porzionato A; Macchi V; De Caro R; Favia G; Palù G
Endocr Relat Cancer; 2008 Dec; 15(4):1115-26. PubMed ID: 18755853
[TBL] [Abstract][Full Text] [Related]
20. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.
Cetani F; Pardi E; Ambrogini E; Viacava P; Borsari S; Lemmi M; Cianferotti L; Miccoli P; Pinchera A; Arnold A; Marcocci C
Endocr Relat Cancer; 2007 Jun; 14(2):493-9. PubMed ID: 17639062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
